The New Jersey Cannabis Regulatory Commission (CRC) is currently developing and implementing rigorous testing requirements to support the medical and adult-use cannabis industry. These regulations will put New Jersey on par with other state’s quality control measures to ensure that medical patients and adult-use consumers receive accurately-labeled and safe products.
US Cannalytics, New Jersey will bring the same quality testing and operational experience we deploy in other medical markets to service its first adult-use program. The laboratory received ISO/IEC 17025:2017 accreditation from A2LA in August of 2021, and is in the process of completing the state application for independent laboratories. Our team is thrilled to begin working with our current multi-state Alternative Treatment Centers (ATCs) clientele, and establish new relationships with locally-owned ATCs.
